MedTrace Logo

Efficacy and Safety Study on Agilis NxT Introducer in AF Patients

NCT00469638 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2019-02-04

No results posted yet for this study

Summary

To prove if the success rate of curative treatment of atrial fibrillation in left atrial circumferential pulmonary vein ablation is higher by using a steerable transseptal introducer giving access to the left atrium then by using a conventionally introducer with fixed curve.

Conditions

Interventions

PROCEDURE

Left atrial catheter ablation guided by introducer using Agilis sheeth

Left atrial catheter ablation guided by introducer using Agilis sheeth

PROCEDURE

Left atrial catheter ablation guided by introducer using Non-steerable sheeth

Left atrial catheter ablation guided by introducer using Non-steerable sheeth

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Gerhard Hindricks, Prof. Dr. · Herzzentrum Leipzig, Abteilung für Rhythmologie, Strümpellstraße 39, 04289 Leipzig, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00469638 on ClinicalTrials.gov